4 research outputs found
Detection of the Presence of Bordetella pertussis by Real-Time Polymerase Chain Reaction in Children Diagnosed with Pertussis and among their Household Contacts
Bacterial Agents Causing Meningitis During 2013-2014 in Turkey: A Multi-Center Hospital-Based Prospective Surveillance Study
This is an observational epidemiological study to describe causes of bacterial meningitis among persons between 1 month and 18 y of age who are hospitalized with suspected bacterial meningitis in 7 Turkish regions. covering 32% of the entire population of Turkey. We present here the results from 2013 and 2014. A clinical case with meningitis was defined according to followings: any sign of meningitis including fever, vomiting, headache, and meningeal irritation in children above one year of age and fever without any documented source, impaired consciousness, prostration and seizures in those < 1 y of age. Single tube multiplex PCR assay was performed for the simultaneous identification of bacterial agents. The specific gene targets were ctrA, bex, and ply for N. meningitidis, Hib, and S. pneumoniae, respectively. PCR positive samples were recorded as laboratory-confirmed acute bacterial meningitis. A total of 665 children were hospitalized for suspected acute meningitis. The annual incidences of acute laboratory-confirmed bacterial meningitis were 0.3 cases / 100,000 population in 2013 and 0.9 cases/100,000 in 2014. Of the 94 diagnosed cases of bacterial meningitis by PCR, 85 (90.4%) were meningococcal and 9 (9.6%) were pneumococcal. Hib was not detected in any of the patients. Among meningococcal meningitis, cases of serogroup Y, A, B and W-135 were 2.4% (n = 2), 3.5% (n = 3), 32.9% (n = 28), and 42.4% (n = 36). No serogroup C was detected among meningococcal cases. Successful vaccination policies for protection from bacterial meningitis are dependent on accurate determination of the etiology of bacterial meningitis. Additionally, the epidemiology of meningococcal disease is dynamic and close monitoring of serogroup distribution is comprehensively needed to assess the benefit of adding meningococcal vaccines to the routine immunization program.Wo
Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey
The etiology of bacterial meningitis in Turkey changed after the implementation of conjugated vaccines against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) in the Turkish National Immunization Program (NIP). Administration of Hib vaccine and PCV-7 (7-valent pneumococcal conjugate vaccine) was implemented in NIP in 2006 and 2009, respectively. In 2011, PCV-7 was replaced with PCV-13. Meningococcal vaccines have not yet been included in Turkish NIP. This prospective study comprised 27 hospitals located in seven regions of Turkey and represented 45% of the population. Children aged between 1 month and 18 years who were hospitalized with suspected meningitis were included. Cerebrospinal fluid (CSF) samples were collected, and bacterial identification was made according to the multiplex PCR assay results. During the study period, 994 children were hospitalized for suspected meningitis, and Hib (n = 3, 2.4%), S. pneumoniae (n = 33, 26.4%), and Neisseria meningitidis (n = 89, 71%) were detected in 125 samples. The most common meningococcal serogroup was MenB. Serogroup W comprised 13.9% (n = 5) and 7.5% (n = 4) of the meningococci in 2015 to 2016 and 2017 to 2018, respectively. Serogroup C was not detected. There were four deaths in the study; one was a pneumococcus case, and the others were serogroup B meningococcus cases. The epidemiology of meningococcal diseases has varied over time in Turkey. Differing from the previous surveillance periods, MenB was the most common serogroup in the 2015-to-2018 period. Meningococcal epidemiology is so dynamic that, for vaccination policies, close monitoring is crucial
Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey
The etiology of bacterial meningitis in Turkey changed after the
implementation of conjugated vaccines against Streptococcus pneumoniae
and Haemophilus influenzae type b (Hib) in the Turkish National
Immunization Program (NIP). Administration of Hib vaccine and PCV-7
(7-valent pneumococcal conjugate vaccine) was implemented in NIP in 2006
and 2009, respectively. In 2011, PCV-7 was replaced with PCV-13.
Meningococcal vaccines have not yet been included in Turkish NIP. This
prospective study comprised 27 hospitals located in seven regions of
Turkey and represented 45\% of the population. Children aged between 1
month and 18 years who were hospitalized with suspected meningitis were
included. Cerebrospinal fluid (CSF) samples were collected, and
bacterial identification was made according to the multiplex PCR assay
results. During the study period, 994 children were hospitalized for
suspected meningitis, and Hib (n = 3, 2.4\%), S. pneumoniae (n = 33,
26.4\%), and Neisseria meningitidis (n = 89, 71\%) were detected in 125
samples. The most common meningococcal serogroup was MenB. Serogroup W
comprised 13.9\% (n = 5) and 7.5\% (n = 4) of the meningococci in 2015
to 2016 and 2017 to 2018, respectively. Serogroup C was not detected.
There were four deaths in the study; one was a pneumococcus case, and
the others were serogroup B meningococcus cases. The epidemiology of
meningococcal diseases has varied over time in Turkey. Differing from
the previous surveillance periods, MenB was the most common serogroup in
the 2015-to-2018 period. Meningococcal epidemiology is so dynamic that,
for vaccination policies, close monitoring is crucial.
IMPORTANCE Acute bacterial meningitis (ABM) is one of the most common
life-threatening infections in children. The incidence and prevalence of
ABM vary both geographically and temporally; therefore, surveillance
systems are necessary to determine the accurate burden of ABM. The
Turkish Meningitis Surveillance Group has been performing a
hospital-based meningitis surveillance study since 2005 across several
regions in Turkey. Meningococcus was the major ABM-causing agent during
the 2015-to-2018 period, during which MenB was the dominant serogroup